Vital Signs - Healthcare News - The Analysts Perspect March 2014 Issue

Vital Signs - Healthcare News - The Analysts Perspect March 2014 Issue

RELEASE DATE
31-Mar-2014
REGION
North America
Research Code: 9A35-00-12-00-00
SKU: LS00215-NA-MR_17480

$450.00

Special Price $337.50 save 25 %

In stock
SKU
LS00215-NA-MR_17480

$450.00

$337.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This issue of Vital Signs, released on March 31, 2014, discusses the premium price tag of Gilead's Sovaldi, Sony's genomic partnership with Illumina, and Craig Venter’s latest venture, Human Longevity, Inc.

Table of Contents

This Week's Issue

Related Research
This issue of Vital Signs, released on March 31, 2014, discusses the premium price tag of Gileads Sovaldi, Sonys genomic partnership with Illumina, and Craig Venters latest venture, Human Longevity, Inc.
More Information
No Index Yes
Podcast No
Author Jennifer Lazar
WIP Number 9A35-00-12-00-00
Is Prebook No